• Sun. May 28th, 2023

Allocation of Mankind Pharma shares: The allocation of Mankind Pharma shares is scheduled for May 3, where investors will receive shares on the basis of a lottery. The whole process will be supervised by the Registrar. However, once the Mankind Pharma IPO award is announced, a bidder does not need to move between pillars. A bidder may check the award status of Mankind Pharma IPO online by logging on to the website of ESB or the website of its official registrar – KFin Technologies Limited.

Subscribers can check the following two direct links and find out if their IPO share has been awarded or not.



How to Check Mankind Pharma IPO Award Status on BSE

1]Connect to BSE direct link — bseindia.com/investors/appli_check.aspx;

2]Select “Equity” in the issue type;

3]Write the application number or the PAN number according to what you have;

4]Click on ‘I’m not a robot’; And

5]Click on the ‘Search’ button.

Your Mankind Pharma IPO award status will be available on your computer screen on your mobile phone screen.

How to Check Mankind Pharma IPO Award Status on KFintech

1]Login to KFintech direct website – kprism.kfintech.com/ipostatus;

2]Select “Mankind Pharma IPO”;

3]Select ‘Application Number’, ‘Demat Account’ or PAN (For convenience, we take the application number here);

4]Enter the request number;

5]Enter Captcha; And

6]Click on the “SUBMIT” option below.

Your Mankind Pharma IPO award status will be available on your computer screen on your mobile phone screen.

Mankind Pharma IPO GMP

According to reports, the latest GMP from Mankind Pharma suggests a premium of Rs 92, suggesting the certificate will make a decent debut on its stock exchange listing.

Mankind Pharma will finalize the share allotment on May 3, 2023. Refunds will begin to be issued on May 4 if subscribers have not yet received the allotment. The shares will be credited to the demat account of the subscribers on May 5 after its allocation. After public subscription, shares of Mankind Pharma are expected to go public on May 8, 2023.

Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are lead managers for the issuance.

About Mankind Pharma IPO

Mankind Pharma is India’s fourth largest pharmaceutical company by domestic sales and third largest by sales volume for rolling annual total as of December 2022.

The initial sale of Rs 4,326 crore shares of Mankind Pharma, which is fully an offer to sell (OFS) was subscribed 15.32 times at the close, driven by strong interest from qualified institutional buyers (QIBs).

The QIB part was subscribed 49 times, the NII bit was subscribed 3.8 times. Retail investors were not very interested because the subscription was less than 100%.

Read all the latest business news, tax news and stock market updates here


Leave a Reply

Your email address will not be published. Required fields are marked *